Screener
Solid Biosciences Inc. SLDB Total Current Assets
Total Current Assets at other companies
Other financials
Where this comes from
Reported directly by Solid Biosciences Inc. in its filing.
Tagged under the XBRL concept us-gaap:AssetsCurrent.
The source filing: Solid Biosciences Inc.’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:04 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-337935
| Line item | June 30, 2026 | December 31, 2025 |
|---|---|---|
| Available-for-sale securities | 218,284 | 127,950 |
| Prepaid expenses and other current assets | 16,792 | 16,384 |
| Restricted cash, current | 638 | 1,222 |
| Total current assets | 395,108 | 205,456 |
| Non-current assets: | ||
| Operating lease, right-of-use assets | 20,667 | 21,924 |
| Property and equipment, net | 3,959 | 4,169 |
| Other non-current assets | 138 | 223 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Solid Biosciences Inc.'s total current assets?
- Solid Biosciences Inc. (SLDB) reported total current assets of $395.11M in Q2 2026.
- How has Solid Biosciences Inc.'s total current assets changed year-over-year?
- Solid Biosciences Inc.'s total current assets increased by 41.8% year-over-year, from $278.64M to $395.11M.
- What is the long-term trend for Solid Biosciences Inc.'s total current assets?
- Over 5 years (2020 to 2025), Solid Biosciences Inc.'s total current assets has grown at a 5.3% compound annual growth rate (CAGR), from $158.9M to $205.46M.
- What does total current assets mean?
- The sum of all assets expected to be converted to cash or consumed within one year — cash, receivables, inventory, and prepaid expenses.
Ask your AI about Solid Biosciences Inc.'s total current assets.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude